Kossan Rubber Industries Bhd (KSRBF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.12 Million MYR | -24.17% |
| 2022 | 6.76 Million MYR | -89.55% |
| 2021 | 64.73 Million MYR | -45.31% |
| 2020 | 118.38 Million MYR | -31.41% |
| 2019 | 172.58 Million MYR | -24.73% |
| 2018 | 229.27 Million MYR | 22.67% |
| 2017 | 186.9 Million MYR | 216.84% |
| 2016 | 58.99 Million MYR | -42.99% |
| 2015 | 103.47 Million MYR | 63.14% |
| 2014 | 63.42 Million MYR | 28.44% |
| 2013 | 49.38 Million MYR | 29.09% |
| 2012 | 38.25 Million MYR | 47.15% |
| 2011 | 25.99 Million MYR | -6.01% |
| 2010 | 27.65 Million MYR | -41.59% |
| 2009 | 47.35 Million MYR | -12.87% |
| 2008 | 54.34 Million MYR | 45.14% |
| 2007 | 37.44 Million MYR | -11.66% |
| 2006 | 42.38 Million MYR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.88 Million MYR | 0.0% |
| 2024 Q1 | 3.88 Million MYR | 0.0% |
| 2023 Q2 | 5.47 Million MYR | -2.09% |
| 2023 Q1 | 5.59 Million MYR | -17.3% |
| 2023 Q4 | 5.12 Million MYR | -6.35% |
| 2023 Q3 | 5.47 Million MYR | 0.0% |
| 2023 FY | 5.12 Million MYR | -24.17% |
| 2022 Q4 | 6.76 Million MYR | -72.78% |
| 2022 Q2 | 37.98 Million MYR | -25.7% |
| 2022 Q1 | 51.12 Million MYR | -21.04% |
| 2022 FY | 6.76 Million MYR | -89.55% |
| 2022 Q3 | 24.84 Million MYR | -34.59% |
| 2021 Q3 | 69.76 Million MYR | -18.79% |
| 2021 Q4 | 64.73 Million MYR | -7.21% |
| 2021 Q1 | 102.04 Million MYR | -13.8% |
| 2021 FY | 64.73 Million MYR | -45.31% |
| 2021 Q2 | 85.9 Million MYR | -15.81% |
| 2020 Q3 | 136.06 Million MYR | -10.03% |
| 2020 Q1 | 166.51 Million MYR | -3.52% |
| 2020 Q2 | 151.23 Million MYR | -9.18% |
| 2020 Q4 | 118.38 Million MYR | -12.99% |
| 2020 FY | 118.38 Million MYR | -31.41% |
| 2019 FY | 172.58 Million MYR | -24.73% |
| 2019 Q4 | 172.58 Million MYR | -9.36% |
| 2019 Q1 | 225.44 Million MYR | -1.67% |
| 2019 Q2 | 209.37 Million MYR | -7.13% |
| 2019 Q3 | 190.4 Million MYR | -9.06% |
| 2018 Q4 | 229.27 Million MYR | -10.12% |
| 2018 Q3 | 255.09 Million MYR | 4.19% |
| 2018 Q1 | 175.86 Million MYR | -5.91% |
| 2018 FY | 229.27 Million MYR | 22.67% |
| 2018 Q2 | 244.84 Million MYR | 39.23% |
| 2017 Q1 | 89.58 Million MYR | 51.87% |
| 2017 FY | 186.9 Million MYR | 216.84% |
| 2017 Q4 | 186.9 Million MYR | 60.59% |
| 2017 Q3 | 116.38 Million MYR | 13.0% |
| 2017 Q2 | 102.99 Million MYR | 14.97% |
| 2016 Q1 | 92.13 Million MYR | -10.96% |
| 2016 FY | 58.99 Million MYR | -42.99% |
| 2016 Q2 | 79.41 Million MYR | -13.81% |
| 2016 Q3 | 65.62 Million MYR | -17.36% |
| 2016 Q4 | 58.99 Million MYR | -10.1% |
| 2015 Q2 | 75.08 Million MYR | 28.11% |
| 2015 Q3 | 104.07 Million MYR | 38.6% |
| 2015 Q4 | 103.47 Million MYR | -0.57% |
| 2015 FY | 103.47 Million MYR | 63.14% |
| 2015 Q1 | 58.61 Million MYR | -7.59% |
| 2014 Q4 | 63.42 Million MYR | -19.49% |
| 2014 Q1 | 44.13 Million MYR | -10.63% |
| 2014 Q3 | 78.78 Million MYR | 79.24% |
| 2014 Q2 | 43.95 Million MYR | -0.41% |
| 2014 FY | 63.42 Million MYR | 28.44% |
| 2013 Q1 | 34.11 Million MYR | -10.84% |
| 2013 FY | 49.38 Million MYR | 29.09% |
| 2013 Q4 | 49.38 Million MYR | 41.54% |
| 2013 Q3 | 34.89 Million MYR | 19.83% |
| 2013 Q2 | 29.11 Million MYR | -14.64% |
| 2012 Q3 | 14.28 Million MYR | -15.83% |
| 2012 FY | 38.25 Million MYR | 47.15% |
| 2012 Q2 | 16.96 Million MYR | -23.89% |
| 2012 Q4 | 38.25 Million MYR | 167.85% |
| 2012 Q1 | 22.29 Million MYR | 0.0% |
| 2011 FY | 25.99 Million MYR | -6.01% |
| 2010 FY | 27.65 Million MYR | -41.59% |
| 2009 FY | 47.35 Million MYR | -12.87% |
| 2008 FY | 54.34 Million MYR | 45.14% |
| 2007 FY | 37.44 Million MYR | -11.66% |
| 2006 FY | 42.38 Million MYR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 99.273% |
| Ansell Limited | 706.6 Million USD | 99.274% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 77.114% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -720.64% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.581% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.582% |
| Encision Inc. | 67.33 Thousand USD | -7517.025% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -1239.735% |
| LifePoint, Inc. | 151.73 Thousand USD | -3280.258% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -4.375% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -733.984% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -2750.03% |
| SmileDirectClub, Inc. | 849.37 Million USD | 99.396% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 97.567% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -10477.657% |
| Vasamed, Inc. | 18.95 Thousand USD | -26965.963% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -27672.363% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -1213.629% |